Patricia Walker
Icahn School of Medicine at Mount Sinai · Candesant Biomedical - Medical Monitor · Botanix Pharmaceuticals
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Patricia Walker as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:05 UTC. Open this list on ClinicalTrials.gov
- N/ANCT04654481 · Study of AffloVest in At-Risk Respiratory Patients During COVID-19 PandemicIcahn School of Medicine at Mount Sinai · terminated · Chronic Obstructive Pulmonary Disease, Chronic Cough, Covid19 · principal investigator
- N/ANCT04599907 · Evaluation of N-SWEAT Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary SweatingCandesant Biomedical, Inc. · completed · Primary Axillary Hyperhidrosis · study director
- Ph3NCT03948646 · Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302)Botanix Pharmaceuticals · completed · Axillary Hyperhidrosis · study director
- Ph3NCT03836287 · Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301)Botanix Pharmaceuticals · completed · Axillary Hyperhidrosis · study director
- Ph2NCT03785587 · A Safety Study of BBI-4000 Gel in Pediatric Patients With Axillary HyperhidrosisBotanix Pharmaceuticals · completed · Primary Axillary Hyperhidrosis · study director
- Ph3NCT03627468 · A Safety Study of BBI-4000 Gel in Patients With Axillary HyperhidrosisBotanix Pharmaceuticals · completed · Primary Axillary Hyperhidrosis · study director
- Ph2NCT03024255 · A Confirmatory Safety and Efficacy Study of BBI-4000 in Subjects With Axillary HyperhidrosisBotanix Pharmaceuticals · completed · Hyperhidrosis · study director
- Ph2NCT02336503 · A Safety and Efficacy Study of BBI-4000 in Subjects With Axillary HyperhidrosisBotanix Pharmaceuticals · completed · Hyperhidrosis · study director
- Ph1NCT01632917 · Open-Label Pharmacokinetic Study of Final Formulations of ATX-101Kythera Biopharmaceuticals · completed · Healthy · study director
- Ph1NCT01462786 · To Evaluate the Safety, Tolerability and to Compare the Pharmacokinetic Profile of ATX-101Kythera Biopharmaceuticals · completed · Healthy · study director
- Ph1NCT01319916 · Lipid and Adipokine Profiles Following Subcutaneous Injection of ATX-101 Into Abdominal Fat TissueKythera Biopharmaceuticals · completed · Healthy · study director
- Ph1NCT01320761 · A Study to Assess Injection Comfort of Two Formulations of ATX-101Kythera Biopharmaceuticals · completed · Healthy · study director
- Ph1NCT00835952 · ATX-101 AbdominoplastyKythera Biopharmaceuticals · completed · Characteristics of Subcutaneous Fat · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:05 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:05 UTC. The ranking covers the 200 most relevant of 152 PubMed records, and a shared surname and initials can bring in a namesake. All 152 on PubMed
- 563 citationsRCR 23.2
- 361 citationsRCR 16.0
- A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines.J Am Acad Dermatol · 2002316 citationsRCR 14.9
- Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial.Lancet Respir Med · 2014269 citationsRCR 8.5
- 262 citationsRCR 16.6
- Inamed silicone breast implant core study results at 6 years.Plast Reconstr Surg · 2007232 citationsRCR 9.3
- Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial.Intensive Care Med · 2018167 citationsRCR 7.4
- 143 citationsRCR 6.8
- Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: a multicenter, double-masked, randomized, within-subject study.Dermatol Surg · 2007131 citationsRCR 6.0
- Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children.Neurosurgery · 2011122 citationsRCR 3.8